Close

Alexion Pharma (ALXN) Asfotase Alfa Granted Orphan Drug Designation in Japan

September 8, 2014 6:33 AM EDT Send to a Friend
Alexion Pharma (Nasdaq: ALXN) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login